These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22689137)

  • 41. Donor Corneal Transplantation vs Boston Type 1 Keratoprosthesis in Patients with Previous Graft Failures: A Retrospective Single Center Study (An American Ophthalmological Society Thesis).
    Akpek EK; Cassard SD; Dunlap K; Hahn S; Ramulu PY
    Trans Am Ophthalmol Soc; 2015; 113():T3. PubMed ID: 26538773
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Infectious keratitis after Boston type 1 keratoprosthesis implantation.
    Chan CC; Holland EJ
    Cornea; 2012 Oct; 31(10):1128-34. PubMed ID: 22960647
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Boston Keratoprosthesis Type 1: A Randomized Controlled Trial of Fresh versus Frozen Corneal Donor Carriers with Long-Term Follow-up.
    Muzychuk AK; Robert MC; Dao S; Harissi-Dagher M
    Ophthalmology; 2017 Jan; 124(1):20-26. PubMed ID: 27566854
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical features and prognosis of Boston type I keratoprosthesis-associated corneal melt.
    Utine CA; Tzu JH; Akpek EK
    Ocul Immunol Inflamm; 2011 Dec; 19(6):413-8. PubMed ID: 22106908
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Boston Keratoprosthesis type 1 (KPro) without contact lens wearing in end-stage corneal disease: The APEC experience.
    De Wit-Carter G; Hernández-Chavarría C; Navarro-Naranjo PI; Manzanillo-Rosario C; Navarro-Saucedo R; García-Albisua AM; Hernandez-Quintela E; Cabrera-Martínez E; Ordoñez-Ranz G; Sanchez-Huerta V
    Eur J Ophthalmol; 2024 Jul; 34(4):1063-1070. PubMed ID: 38099653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic hypotony associated with the Boston type 1 keratoprosthesis.
    Dokey A; Ramulu PY; Utine CA; Tzu JH; Eberhart CG; Shan S; Gelhbach PL; Akpek EK
    Am J Ophthalmol; 2012 Aug; 154(2):266-271.e1. PubMed ID: 22633347
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical Outcomes Using Oversized Back Plates in Type I Boston Keratoprosthesis.
    Kaufman AR; Cruzat A; Colby KA
    Eye Contact Lens; 2018 Nov; 44(6):399-404. PubMed ID: 29219899
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes of bilateral sequential implantation of the Boston keratoprosthesis type 1.
    Vaillancourt L; Papanagnu E; Elfekhfakh M; Fadous R; Harissi-Dagher M
    Can J Ophthalmol; 2017 Feb; 52(1):80-84. PubMed ID: 28237154
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Current treatment options with artificial corneas: Boston Kpro, Osteo-odontokeratoprosthesis, Miro Cornea® and KeraKlear®].
    Schrage N; Hille K; Cursiefen C
    Ophthalmologe; 2014 Nov; 111(11):1010-8. PubMed ID: 25388085
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Scanning Electron Microscopic Analysis of Biofilm Formation in Explanted Human Boston Type I Keratoprostheses.
    Sivaraman KR; Hou JH; Chang JH; Behlau I; Cortina MS; Cruz Jde L
    Cornea; 2016 Jan; 35(1):25-9. PubMed ID: 26562818
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Boston Type 1 Keratoprosthesis: Visual Outcomes, Device Retention, and Complications.
    Goins KM; Kitzmann AS; Greiner MA; Kwon YH; Alward WL; Ledolter J; Wagoner MD
    Cornea; 2016 Sep; 35(9):1165-74. PubMed ID: 27191675
    [TBL] [Abstract][Full Text] [Related]  

  • 52. International results with the Boston type I keratoprosthesis.
    Aldave AJ; Sangwan VS; Basu S; Basak SK; Hovakimyan A; Gevorgyan O; Kharashi SA; Jindan MA; Tandon R; Mascarenhas J; Malyugin B; Padilla MD; Maskati Q; Agarwala N; Hutauruk J; Sharma M; Yu F
    Ophthalmology; 2012 Aug; 119(8):1530-8. PubMed ID: 22512986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
    Greiner MA; Li JY; Mannis MJ
    Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcomes of the Boston type 1 and the Aurolab keratoprosthesis in eyes with limbal stem cell deficiency.
    Shanbhag SS; Senthil S; Mohamed A; Basu S
    Br J Ophthalmol; 2021 Apr; 105(4):473-478. PubMed ID: 32554443
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Boston keratoprosthesis outcomes and complications.
    Chew HF; Ayres BD; Hammersmith KM; Rapuano CJ; Laibson PR; Myers JS; Jin YP; Cohen EJ
    Cornea; 2009 Oct; 28(9):989-96. PubMed ID: 19724214
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Boston keratoprosthesis type I in the elderly.
    Homayounfar G; Grassi CM; Al-Moujahed A; Colby KA; Dohlman CH; Chodosh J
    Br J Ophthalmol; 2017 Apr; 101(4):514-518. PubMed ID: 27381593
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Short-Term Outcomes of Pediatric Keratoprosthesis With the Near-Complete Conjunctival Flap.
    Bawany MH; Kudla C; Khan FA; Chung MM; Aquavella JV
    Cornea; 2021 Jun; 40(6):679-684. PubMed ID: 33941714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Review of clinical trials addressing the Boston Keratoprosthesis.
    Milad D; Yang Y; Eisa K; Harissi-Dagher M
    Can J Ophthalmol; 2024 Aug; 59(4):e309-e320. PubMed ID: 37253429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Causes of Corneal Melt After the Boston Keratoprosthesis Type I: The Chinese People's Liberation Army General Hospital Experience.
    Yang Z; Wang YQ; Wang Q; Xu W; Zhang S; Li Z; Huang Y; Huang YF; Wang LQ
    Cornea; 2024 Aug; 43(8):936-941. PubMed ID: 38713491
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Frozen versus fresh corneal graft carriers in Boston keratoprosthesis surgery: 10-year outcomes.
    Sabeti S; Daoud R; Robert MC; Harissi-Dagher M
    Can J Ophthalmol; 2022 Apr; 57(2):127-133. PubMed ID: 33781724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.